1. Home
  2. HKD vs RCKT Comparison

HKD vs RCKT Comparison

Compare HKD & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HKD

AMTD Digital Inc. (every five of which represent two)

HOLD

Current Price

$1.56

Market Cap

446.3M

Sector

Finance

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$4.43

Market Cap

503.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HKD
RCKT
Founded
2003
1999
Country
France
United States
Employees
N/A
202
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
446.3M
503.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
HKD
RCKT
Price
$1.56
$4.43
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
$29.65
AVG Volume (30 Days)
681.5K
2.6M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$2.19
52 Week High
$5.47
$8.91

Technical Indicators

Market Signals
Indicator
HKD
RCKT
Relative Strength Index (RSI) 50.04 60.56
Support Level $1.32 $2.99
Resistance Level $1.68 $4.51
Average True Range (ATR) 0.15 0.34
MACD -0.02 0.07
Stochastic Oscillator 22.30 57.31

Price Performance

Historical Comparison
HKD
RCKT

About HKD AMTD Digital Inc. (every five of which represent two)

AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment, hotel operations, hospitality and VIP services segment and media and entertainment services. The company generates maximum revenue by providing financial digital solutions through its insurance brokerage services and other digital solutions services. Geographically, the company generates maximum revenue from Hong Kong and Singapore.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: